Administration of a CO-releasing molecule induces late preconditioning against myocardial infarction

Journal of Molecular and Cellular Cardiology

Volumn 38, Issue 1, 2005, Pages 127-134

  Stein, Adam B ^a   Guo, Yiru ^a   Tan, Wei ^a   Wu, Wen Jian ^a   Zhu, Xiaoping ^a   Li, Qianhong ^a   Luo, Cheng ^a   Dawn, Buddhadeb ^a   Johnson, Tony R ^b   Motterlini, Roberto ^c   Bolli, Roberto ^a  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

^c NORTHWICK PARK INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

Author keywords

Carbon monoxide releasing molecules; Myocardial infarction; Preconditioning

Indexed keywords

CARBON MONOXIDE; RUTHENIUM DERIVATIVE; TRICARBONYLCHLORO(GLYCINATO)RUTHENIUM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HEART INFARCTION; HEART INFARCTION SIZE; HEART PROTECTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REPERFUSION;

ANIMALS; BODY TEMPERATURE; BODY WEIGHT; CARBON MONOXIDE; HEART RATE; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; MICE; MICE, INBRED ICR; MYOCARDIAL INFARCTION; ORGAN SIZE; ORGANOMETALLIC COMPOUNDS; RISK FACTORS;

EID: 19944371683     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2004.10.006     Document Type: Article

References (51)

1. B. Chance, M. Erecinska, and M. Wagner Mitochondrial responses to carbon monoxide toxicity Ann. N. Y. Acad. Sci. 174 1970 193 204
2. R. Motterlini, A. Gonzales, R. Foresti, J.E. Clark, C.J. Green, and R.M. Winslow Heme oxygenase-1-derived carbon monoxide contributes to the suppression of acute hypertensive responses in vivo Circ. Res. 83 1998 568 577
3. I.A. Sammut, R. Foresti, J.E. Clark, D.J. Exon, M.J. Vesely, and P. Sarathchandra Carbon monoxide is a major contributor to the regulation of vascular tone in aortas expressing high levels of haeme oxygenase-1 Br. J. Pharmacol. 125 1998 1437 1444
4. R. Song, R.S. Mahidhara, F. Liu, W. Ning, L.E. Otterbein, and A.M. Choi Carbon monoxide inhibits human airway smooth muscle cell proliferation via mitogen-activated protein kinase pathway Am J Respir Cell Mol Biol 27 2002 603 610
5. J.E. Clark, P. Naughton, S. Shurey, C.J. Green, T.R. Johnson, and B.E. Mann Cardioprotective actions by a water-soluble carbon monoxide-releasing molecule Circ Res 93 2003 e2 e8
6. L.E. Otterbein Carbon monoxide: innovative anti-inflammatory properties of an age-old gas molecule Antioxid Redox Signal 4 2002 309 319
7. L.E. Otterbein, F.H. Bach, J. Alam, M. Soares, H. Tao Lu, and M. Wysk Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway Nat. Med. 6 2000 422 428
8. B. Brune, and V. Ullrich Inhibition of platelet aggregation by carbon monoxide is mediated by activation of guanylate cyclase Mol. Pharmacol. 32 1987 497 504
9. T. Minamino, H. Christou, C.M. Hsieh, Y. Liu, V. Dhawan, and N.G. Abraham Targeted expression of heme oxygenase-1 prevents the pulmonary inflammatory and vascular responses to hypoxia Proc Natl Acad Sci USA 98 2001 8798 8803
10. J.K. Sarady, S.L. Otterbein, F. Liu, L.E. Otterbein, and A.M. Choi Carbon monoxide modulates endotoxin-induced production of granulocyte macrophage colony-stimulating factor in macrophages Am J Respir Cell Mol Biol 27 2002 739 745
11. L.E. Otterbein, L.L. Mantell, and A.M. Choi Carbon monoxide provides protection against hyperoxic lung injury Am. J. Physiol. 276 1999 L688 L694
12. F. Amersi, X.D. Shen, D. Anselmo, J. Melinek, S. Iyer, and D.J. Southard Ex vivo exposure to carbon monoxide prevents hepatic ischemia/reperfusion injury through p38 MAP kinase pathway Hepatology 35 2002 815 823
13. Y. Guo, A.B. Stein, W.J. Wu, W. Tan, X. Zhu, and Q.H. Li Administration of a CO-releasing molecule at the time of reperfusion reduces infarct size in vivo Am J Physiol Heart Circ Physiol 286 2004 H1649 H1653
14. L. Gunther, P.O. Berberat, M. Haga, S. Brouard, R.N. Smith, and M.P. Soares Carbon monoxide protects pancreatic beta-cells from apoptosis and improves islet function/survival after transplantation Diabetes 51 2002 994 999
15. S. Brouard, L.E. Otterbein, J. Anrather, E. Tobiasch, F.H. Bach, and A.M. Choi Carbon monoxide generated by heme oxygenase 1 suppresses endothelial cell apoptosis J. Exp. Med. 192 2000 1015 1026
16. L. Otterbein, M. Soares, K. Yamashita, and F. Bach Heme oxygenase-1: unleashing the protective properties of heme Trends Immunol 24 2003 449 455
17. R. Motterlini, J.E. Clark, R. Foresti, P. Sarathchandra, B.E. Mann, and C.J. Green Carbon monoxide-releasing molecules: characterization of biochemical and vascular activities Circ Res 90 2002 E17 E24
18. B.S. Zuckerbraun, T.R. Billiar, S.L. Otterbein, P.K. Kim, F. Liu, and A.M. Choi Carbon monoxide protects against liver failure through nitric oxide-induced heme oxygenase 1 J Exp Med 198 2003 1707 1716
19. Y. Guo, Y.T. Xuan, W.J. Wu, X. Zhu, W. Tan, and Y. Zhu Hemeoxygenase-1 mediates three different types of late preconditioning Circulation 108 IV 2003 93 [Abstract]
20. Y. Guo, W.K. Jones, Y.T. Xuan, X.L. Tang, W. Bao, and W.J. Wu The late phase of ischemic preconditioning is abrogated by targeted disruption of the inducible NO synthase gene Proc. Natl. Acad. Sci. USA 96 1999 11507 11512
21. N. Maulik, D.T. Engelman, M. Watanabe, R.M. Engelman, and D.K. Das Nitric oxide--a retrograde messenger for carbon monoxide signaling in ischemic heart Mol. Cell. Biochem. 157 1996 75 86
22. N. Maulik, D.T. Engelman, M. Watanabe, R.M. Engelman, J.A. Rousou, and J.E. Flack 3rd Nitric oxide/carbon monoxide. A molecular switch for myocardial preservation during ischemia Circulation 94 1996 II398 II406
23. R. Bolli The late phase of preconditioning Circ. Res. 87 2000 972 983
24. S. Banerjee, X.L. Tang, Y. Qiu, H. Takano, S. Manchikalapudi, and B. Dawn Nitroglycerin induces late preconditioning against myocardial stunning via a PKC-dependent pathway Am. J. Physiol. 277 1999 H2488 H2494
25. M. Hill, H. Takano, X.L. Tang, E. Kodani, G. Shirk, and R. Bolli Nitroglycerin induces late preconditioning against myocardial infarction in conscious rabbits despite development of nitrate tolerance Circulation 104 2001 694 699
26. P. Ping, H. Takano, J. Zhang, X.L. Tang, Y. Qiu, and R.C. Li Isoform-selective activation of protein kinase C by nitric oxide in the heart of conscious rabbits: a signaling mechanism for both nitric oxide-induced and ischemia-induced preconditioning Circ. Res. 84 1999 587 604
27. H. Takano, X.L. Tang, Y. Qiu, Y. Guo, B.A. French, and R. Bolli Nitric oxide donors induce late preconditioning against myocardial stunning and infarction in conscious rabbits via an antioxidant-sensitive mechanism Circ. Res. 83 1998 73 84
28. X.L. Tang, E. Kodani, H. Takano, M. Hill, K. Shinmura, and T.M. Vondriska Protein tyrosine kinase signaling is necessary for NO donor-induced late preconditioning against myocardial stunning Am J Physiol Heart Circ Physiol 284 2003 H1441 H1448
29. G.F. Baxter, M.S. Marber, V.C. Patel, and D.M. Yellon Adenosine receptor involvement in a delayed phase of myocardial protection 24:h after ischemic preconditioning Circulation 90 1994 2993 3000
30. H. Takano, R. Bolli, R.G. Black Jr., E. Kodani, X.L. Tang, and Z. Yang A1 or A3 adenosine receptors induce late preconditioning against infarction in conscious rabbits by different mechanisms Circ Res 88 2001 520 528
31. R.M. Fryer, A.K. Hsu, J.T. Eells, H. Nagase, and G.J. Gross Opioid-induced second window of cardioprotection: potential role of mitochondrial KATP channels Circ. Res. 84 1999 846 851
32. R.M. Fryer, A.K. Hsu, H. Nagase, and G.J. Gross Opioid-induced cardioprotection against myocardial infarction and arrhythmias: mitochondrial versus sarcolemmal ATP-sensitive potassium channels J. Pharmacol. Exp. Ther. 294 2000 451 457
33. A. Tsuchida, T. Miura, M. Tanno, J. Sakamoto, T. Miki, and A. Kuno Infarct size limitation by nicorandil: roles of mitochondrial K(ATP) channels, sarcolemmal K(ATP) channels, and protein kinase C. J Am Coll Cardiol 40 2002 1523 1530
34. L. Xi, N.C. Jarrett, M.L. Hess, and R.C. Kukreja Essential role of inducible nitric oxide synthase in monophosphoryl lipid A-induced late cardioprotection: evidence from pharmacological inhibition and gene knockout mice Circulation 99 1999 2157 2163
35. Z. Yao, J.A. Auchampach, G.M. Pieper, and G.J. Gross Cardioprotective effects of monophosphoryl lipid A, a novel endotoxin analogue, in the dog Cardiovasc. Res. 27 1993 832 838
36. R. Ockaili, V.R. Emani, S. Okubo, M. Brown, K. Krottapalli, and R.C. Kukreja Opening of mitochondrial KATP channel induces early and delayed cardioprotective effect: role of nitric oxide Am. J. Physiol. Heart Circ. Physiol. 277 1999 H2425 H2434
37. E. Takashi, Y. Wang, and M. Ashraf Activation of mitochondrial K(ATP) channel elicits late preconditioning against myocardial infarction via protein kinase C signaling pathway Circ. Res. 85 1999 1146 1153
38. X.L. Tang, Y.T. Xuan, Y. Zhu, G. Shirk, and R. Bolli Nicorandil induces late preconditioning against myocardial infarction in conscious rabbits Am J Physiol Heart Circ Physiol 286 4 2004 1273 1280
39. Y. Guo, W.J. Wu, Y. Qiu, X.L. Tang, Z. Yang, and R. Bolli Demonstration of an early and a late phase of ischemic preconditioning in mice Am. J. Physiol. 275 1998 H1375 H1387
40. S. Wallenstein, C.L. Zucker, and J.L. Fleiss Some statistical methods useful in circulation research Circ. Res. 47 1980 1 9
41. S.G. Fisher, and M.S. Marber An in vivo model of ischaemia-reperfusion injury and ischaemic preconditioning in the mouse heart J Pharmacol Toxicol Methods 48 2002 161 169
42. Y. Guo, W. Bao, W.J. Wu, K. Shinmura, X.L. Tang, and R. Bolli Evidence for an essential role of cyclooxygenase-2 as a mediator of the late phase of ischemic preconditioning in mice Basic Res. Cardiol. 95 2000 479 484
43. N. Maulik, T. Yoshida, and D.K. Das Regulation of cardiomyocyte apoptosis in ischemic reperfused mouse heart by glutathione peroxidase Mol. Cell. Biochem. 196 1999 13 21
44. D.L. Miller, and D.M. Van Winkle Ischemic preconditioning limits infarct size following regional ischemia-reperfusion in in situ mouse hearts Cardiovasc. Res. 42 1999 680 684
45. M.S. Sumeray, and D.M. Yellon Ischaemic preconditioning reduces infarct size following global ischaemia in the murine myocardium Basic Res. Cardiol. 93 1998 384 390
46. Y. Wang, M. Kudo, M. Xu, A. Ayub, and M. Ashraf Mitochondrial K(ATP) channel as an end effector of cardioprotection during late preconditioning: triggering role of nitric oxide J Mol Cell Cardiol 33 2001 2037 2046
47. L. Xi, M.L. Hess, and R.C. Kukreja Ischemic preconditioning in isolated perfused mouse heart: reduction in infarct size without improvement of post-ischemic ventricular function Mol. Cell. Biochem. 186 1998 69 77
48. G. Yamaura, T. Turoczi, F. Yamamoto, M.A. Siddqui, N. Maulik, and D.K. Das STAT signaling in ischemic heart: a role of STAT5A in ischemic preconditioning Am J Physiol Heart Circ Physiol 285 2003 H476 H482
49. Y.T. Xuan, Y. Guo, H. Han, Y. Zhu, and R. Bolli An essential role of the JAK-STAT pathway in ischemic preconditioning Proc Natl Acad Sci USA 98 2001 9050 9055
50. R. Schulz, S. Belosjorow, P. Gres, J. Jansen, M.C. Michel, and G. Heusch p38 MAP kinase is a mediator of ischemic preconditioning in pigs Cardiovasc Res 55 2002 690 700
51. X. Zhang, P. Shan, L.E. Otterbein, J. Alam, R.A. Flavell, and R.J. Davis Carbon monoxide inhibition of apoptosis during ischemia-reperfusion lung injury is dependent on the p38 mitogen-activated protein kinase pathway and involves caspase 3 J Biol Chem 278 2003 1248 1258